aldosterone has been researched along with Active Hyperemia in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vascular function, including reactive hyperemia index (RHI), flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation (NID), arterial stiffness including brachial-ankle pulse wave velocity (baPWV) and brachial intima-media thickness (IMT) and ROCK activity in peripheral leukocytes were measured before and after 12 weeks of treatment with eplerenone in 50 patients with IHA." | 7.91 | Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study. ( Aibara, Y; Chayama, K; Goto, C; Hashimoto, H; Higashi, Y; Kajikawa, M; Kihara, Y; Kishimoto, S; Liao, JK; Maruhashi, T; Matsui, S; Nakashima, A; Noma, K; Oki, K; Takaeko, Y; Yusoff, FM, 2019) |
| "Vascular function, including reactive hyperemia index (RHI), flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation (NID), arterial stiffness including brachial-ankle pulse wave velocity (baPWV) and brachial intima-media thickness (IMT) and ROCK activity in peripheral leukocytes were measured before and after 12 weeks of treatment with eplerenone in 50 patients with IHA." | 3.91 | Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study. ( Aibara, Y; Chayama, K; Goto, C; Hashimoto, H; Higashi, Y; Kajikawa, M; Kihara, Y; Kishimoto, S; Liao, JK; Maruhashi, T; Matsui, S; Nakashima, A; Noma, K; Oki, K; Takaeko, Y; Yusoff, FM, 2019) |
| "Vascular function, including reactive hyperemia index (RIH), flow-mediated vasodilation (FMD), and nitroglycerine-induced vasodilation (NID) were evaluated in 52 patients with IHA, 53 patients with aldosterone-producing adenoma (APA), and 52 age-, sex-, and blood pressure-matched patients with essential hypertension (EHT)." | 1.48 | Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism. ( Hashimoto, H; Higashi, Y; Kajikawa, M; Kihara, Y; Kishimoto, S; Maruhashi, T; Matsui, S; Matsumoto, T; Oki, K; Yusoff, FM, 2018) |
| "Hyperaldosteronism was diagnosed on the basis of a renin activity <1." | 1.32 | Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. ( Calhoun, DA; Green, SA; Nishizaka, MK; Renfroe, KY; Zaman, MA, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kishimoto, S | 2 |
| Matsumoto, T | 1 |
| Oki, K | 2 |
| Maruhashi, T | 2 |
| Kajikawa, M | 2 |
| Matsui, S | 2 |
| Hashimoto, H | 2 |
| Kihara, Y | 2 |
| Yusoff, FM | 2 |
| Higashi, Y | 2 |
| Takaeko, Y | 1 |
| Chayama, K | 1 |
| Goto, C | 1 |
| Aibara, Y | 1 |
| Nakashima, A | 1 |
| Noma, K | 1 |
| Liao, JK | 1 |
| Lan, WR | 1 |
| Hou, CJ | 1 |
| Yen, CH | 1 |
| Shih, BF | 1 |
| Wang, AM | 1 |
| Lee, TY | 1 |
| Tsai, CH | 1 |
| Yeh, HI | 1 |
| BALL, WC | 1 |
| DAVIS, JO | 2 |
| YATES, FE | 2 |
| URQUHART, J | 1 |
| HERBST, AL | 1 |
| AYERS, CR | 1 |
| LIEBERMAN, F | 1 |
| CARPENTER, CC | 1 |
| BERMAN, M | 1 |
| Nishizaka, MK | 1 |
| Zaman, MA | 1 |
| Green, SA | 1 |
| Renfroe, KY | 1 |
| Calhoun, DA | 1 |
8 other studies available for aldosterone and Active Hyperemia
| Article | Year |
|---|---|
Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism.
Topics: Adult; Aldosterone; Blood Pressure; Endothelium, Vascular; Essential Hypertension; Female; Humans; H | 2018 |
Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study.
Topics: Adult; Aldosterone; Ankle Brachial Index; Antihypertensive Agents; Blood Pressure; Brachial Artery; | 2019 |
Effects of carbenoxolone on flow-mediated vasodilatation in healthy adults.
Topics: Administration, Oral; Adult; Aldosterone; Atrial Natriuretic Factor; Brachial Artery; Carbenoxolone; | 2011 |
Failure of chronic adrenal venous congestion to produce sodium retention and increased aldosterone excretion in the dog.
Topics: Adrenal Cortex; Aldosterone; Animals; Dogs; Hyperemia; Hypernatremia; Sodium; Sodium, Dietary; Venae | 1957 |
Effects of central venous congestion on sodium, potassium and water metabolism in the rat; response to desoxycorticosterone.
Topics: Aldosterone; Animals; Body Fluids; Desoxycorticosterone; Heart Failure; Hyperemia; Liver; Portal Sys | 1958 |
Impairment of the enzymatic inactivation of adrenal cortical hormones following passive venous congestion of the liver.
Topics: Adrenal Cortex Hormones; Aldosterone; Heart Failure; Histamine; Histamine Agents; Humans; Hyperemia; | 1958 |
The effects of chronic hepatic venous congestion on the metabolism of d,1-aldosterone and d-aldosterone.
Topics: Aldosterone; Hepatic Veins; Humans; Hyperemia; Lipid Metabolism; Liver; Tritium | 1962 |
Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism.
Topics: Adult; Aldosterone; Brachial Artery; Endothelium, Vascular; Female; Hemorheology; Humans; Hyperaldos | 2004 |